Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

  1. Lobbyist name (consultant or in-house lobbyist): BELLEHUMEUR, CONRAD OR;
  2. Responsible officer name: BELLEHUMEUR, CONRAD
Share this search Create an alert

Refine registrations results by

Status Type Subject matter Government institutions

Refine monthly communication reports results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (24)
Results: 1-24 | Export
  1. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 102 of 113 (2023-04-28 to 2023-06-09)
    Posted: 2023-05-05
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  2. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 101 of 113 (2022-12-12 to 2023-04-28)
    Posted: 2022-12-14
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 12
  3. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 100 of 113 (2022-11-07 to 2022-12-12)
    Posted: 2022-11-09
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  4. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 99 of 113 (2022-09-16 to 2022-11-07)
    Posted: 2022-09-26
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 10
  5. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 98 of 113 (2022-09-07 to 2022-09-16)
    Posted: 2022-09-07
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  6. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 97 of 113 (2022-07-25 to 2022-09-07)
    Posted: 2022-07-26
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  7. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 96 of 113 (2022-06-08 to 2022-07-25)
    Posted: 2022-06-08
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  8. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 95 of 113 (2022-05-11 to 2022-06-08)
    Posted: 2022-05-11
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  9. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 94 of 113 (2022-03-18 to 2022-05-11)
    Posted: 2022-04-13
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 13
  10. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 93 of 113 (2021-12-14 to 2022-03-18)
    Posted: 2021-12-14
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 13
  11. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 92 of 113 (2021-10-22 to 2021-12-14)
    Posted: 2021-10-22
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 12
  12. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 91 of 113 (2021-10-04 to 2021-10-22)
    Posted: 2021-10-05
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 14
  13. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 90 of 113 (2021-08-26 to 2021-10-04)
    Posted: 2021-08-26
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 14
  14. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 89 of 113 (2021-07-13 to 2021-08-26)
    Posted: 2021-07-13
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 13
  15. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 88 of 113 (2021-03-01 to 2021-07-13)
    Posted: 2021-03-01
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 14
  16. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 87 of 113 (2021-02-16 to 2021-03-01)
    Posted: 2021-02-16
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 14
  17. Thales Canada Inc.
    Type: In-house Corporation
    Responsible officer: Paul Kahn, President and CEO
    Registration: 7 of 48 (2012-04-18 to 2013-04-02)
    Posted: 2012-04-19
    Subject matter details: 4
    Government institutions: 15
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 9
  18. Thales Canada Inc.
    Type: In-house Corporation
    Responsible officer: Paul Kahn, President and CEO
    Registration: 6 of 48 (2012-01-31 to 2012-04-18)
    Posted: 2012-01-31
    Subject matter details: 4
    Government institutions: 15
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 7
  19. Thales Canada Inc.
    Type: In-house Corporation
    Responsible officer: Paul Kahn, President and CEO
    Registration: 5 of 48 (2011-05-16 to 2012-01-31)
    Posted: 2011-05-17
    Subject matter details: 3
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  20. Thales Canada Inc.
    Type: In-house Corporation
    Responsible officer: Paul Kahn, President and CEO
    Registration: 4 of 48 (2010-10-19 to 2011-05-16)
    Posted: 2010-11-01
    Subject matter details: 3
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  21. Thales Canada Inc.
    Type: In-house Corporation
    Responsible officer: Paul Kahn, Président, Chef de la Direction
    Registration: 3 of 48 (2010-10-14 to 2010-10-19)
    Posted: 2010-10-14
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  22. NAV CANADA (NAVCAN)
    Type: In-house Organization
    Responsible officer: JOHN CRICHTON, PRESIDENT & CHIEF EXECUTIVE OFFICER
    Registration: 3 of 88 (1999-10-04 to 2000-05-08)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 2
    Government institutions: 18
    Communication techniques: 4
    Government funding: No
    Employees who lobby: 116
  23. NAV CANADA (NAVCAN)
    Type: In-house Organization
    Responsible officer: JOHN CRICHTON, PRESIDENT & CHIEF EXECUTIVE OFFICER
    Registration: 2 of 88 (1999-03-02 to 1999-10-04)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 2
    Government institutions: 18
    Communication techniques: 4
    Government funding: No
    Employees who lobby: 111
  24. NAV CANADA (NAVCAN)
    Type: In-house Organization
    Responsible officer: JOHN CRICHTON, PRESIDENT & CHIEF EXECUTIVE OFFICER
    Registration: 1 of 88 (1998-08-17 to 1999-03-02)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 2
    Government institutions: 18
    Communication techniques: 4
    Government funding: No
    Employees who lobby: 107

Date Modified: